Cargando…

Clinical experience of prophylactic enoxaparin dosage adjustment guided by AntiXa factor levels in critical care patients with COVID-19-induced pneumonia: observational study()

Detalles Bibliográficos
Autores principales:	Bermúdez-Ruiz, María del Carmen, Vilar Sánchez, Irene, Aparicio Pérez, Clara, Carmona Flores, Rosario, Rodríguez-Gómez, Jorge, de la Fuente-Martos, Carmen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier España, S.L.U. 2023
Materias:	Scientific Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201310/ https://www.ncbi.nlm.nih.gov/pubmed/37308357 http://dx.doi.org/10.1016/j.medine.2023.05.009

Ejemplares similares

Experiencia del ajuste de dosificación de enoxaparina profiláctica dirigida con niveles de factor anti-Xa en pacientes críticos con neumonía COVID-19: estudio observacional
por: del Carmen Bermúdez-Ruiz, María, et al.
Publicado: (2023)

Supratherapeutic anti-factor Xa levels in patients receiving prophylactic doses of enoxaparin: A case series
por: Pannucci, Christopher J., et al.
Publicado: (2016)

Factor Xa Levels in Patients Receiving Prophylactic Enoxaparin Sodium in the Intensive Care Unit of an Academic Hospital
por: Baloo, Mayank M, et al.
Publicado: (2021)

Evaluation of prophylactic dosages of Enoxaparin in non-surgical elderly patients with renal impairment
por: Chamoun, Nibal, et al.
Publicado: (2019)

Effective dosage of enoxaparin for intensive care patients
por: Robinson, S, et al.
Publicado: (2013)

Use of anti-Xa factor titration as efficacy marker of enoxaparin in critically ill patients
por: Lage, S, et al.
Publicado: (2006)

Anti-factor Xa levels in obese patients receiving enoxaparin for treatment and prophylaxis indications
por: Tahaineh, Linda, et al.
Publicado: (2018)

742 Evaluation of Anti-Xa Levels and Venous Thromboembolism Prophylaxis with Enoxaparin in Burn Patients
por: Boyd, Allison, et al.
Publicado: (2023)

Pharmacist recommendations for prophylactic enoxaparin monitoring and dose adjustment in trauma patients admitted to a surgical intensive care unit
por: Scrimenti, Ali, et al.
Publicado: (2019)

Preliminary report of an enoxaparin dose protocol based on anti-Xa activity in continuous renal replacement therapy
por: Costa, JLF, et al.
Publicado: (2007)

Assessment of anti-factor Xa activity of enoxaparin for venous thromboembolism prophylaxis in morbidly obese surgical patients
por: Al Otaib, Nouf, et al.
Publicado: (2017)

Value of venous thromboembolism prophylaxis by enoxaparin with anti-factor Xa trough concentration monitoring in surgical care
por: Zachariah, Seeba, et al.
Publicado: (2020)

Comparison of Anti-factor Xa Levels in Female and Male Patients with Obesity After Enoxaparin Application for Thromboprophylaxis
por: Wagner, Jonas, et al.
Publicado: (2022)

Antifactor Xa Levels in Critically Ill Korean Patients Receiving Enoxaparin for Thromboprophylaxis: A Prospective Observational Study
por: Lim, So Yeon, et al.
Publicado: (2013)

A Retrospective Comparative Cohort Study of Craniotomy and Prophylactic Enoxaparin Timing
por: Hallan, David R, et al.
Publicado: (2022)

The effect of a new direct Factor Xa inhibitor on human osteoblasts: an in-vitro study comparing the effect of rivaroxaban with enoxaparin
por: Solayar, Gandhi N, et al.
Publicado: (2011)

An in vitro study to investigate the interference of enoxaparin on plasma levels of direct oral factor Xa inhibitors measured by chromogenic assays
por: Cini, Michela, et al.
Publicado: (2019)

Standard- versus intermediate-dose enoxaparin for anti-factor Xa guided thromboprophylaxis in critically ill patients with COVID-19
por: Hamilton, David Oliver, et al.
Publicado: (2021)

Anti-Xa Activity of Enoxaparin for Prevention of Venous Thromboembolism in Severe Nephrotic Syndrome—A Single Center Prospective Study
por: Matyjek, Anna, et al.
Publicado: (2021)

Bedside anti-Xa measurement for therapeutic assessment of a prophylactic anticoagulation regimen
por: Dewulf, B, et al.
Publicado: (2013)

Prophylactic anticoagulation with low dose enoxaparin: is the subcutaneous route appropriate in the critically ill?
por: Priglinger, U, et al.
Publicado: (2002)

The Levels of Tissue Factor Pathway Inhibitor in Sepsis Patients Receiving Prophylactic Enoxaparin
por: Al Otair, Hadil A., et al.
Publicado: (2016)

Enoxaparin, effective dosage for intensive care patients: double-blinded, randomised clinical trial
por: Robinson, Sian, et al.
Publicado: (2010)

Personalized prophylactic anticoagulation in hospitalized patients with Covid-19 – The role of anti-Xa monitoring
por: Kofteridis, Diamantis P., et al.
Publicado: (2021)

Admission thrombelastography does not guide dose adjustment of enoxaparin in trauma patients
por: Hayes, Hannah V., et al.
Publicado: (2020)

Anti-Factor Xa Levels in Low-weight Surgical Patients Receiving Enoxaparin for Venous Thromboembolism Prophylaxis: A Prospective Cohort Study
por: Hakeam, Hakeam A., et al.
Publicado: (2020)

Anti-factor Xa Activity Is Not Associated With Venous Thromboembolism in Critically Ill Patients Receiving Enoxaparin for Thromboprophylaxis: A Retrospective Observational Study
por: Dibiasi, Christoph, et al.
Publicado: (2022)

Critically ill patients with edema and ascites may experience subtherapeutic anti-factor Xa levels following abdominal subcutaneous enoxaparin treatment
por: Tharanon, Vichapat, et al.
Publicado: (2022)

The Role of Prophylactic Antibiotics in Elective Laparoscopic Cholecystectomy
por: Uludag, Mehmet, et al.
Publicado: (2009)

Ischemic stroke and dose adjustment of oral Factor Xa inhibitors in patients with atrial fibrillation
por: Stoll, Svenja, et al.
Publicado: (2020)

Dosage reduction of low weight heparin in patients with renal dysfunction: Effects on anti-Xa levels and clinical outcomes
por: Hornung, Paul, et al.
Publicado: (2020)

Predicted Vancomycin Dosage Requirement in Patients With Hematological Malignancies and Dosage Dynamic Adjustment
por: Song, Xiangqing, et al.
Publicado: (2022)

Morphine After Tubal Ligation With Bupivacaine: Dosage Versus Body Weight
por: Roehl, Bryan C., et al.
Publicado: (2014)

The Impact of Continuous Veno-Venous Hemodiafiltration on the Efficacy of Administration of Prophylactic Doses of Enoxaparin: A Prospective Observational Study
por: Aszkiełowicz, Aleksander, et al.
Publicado: (2023)

The Rate of Antibiotic Dosage Adjustment in Renal Dysfunction
por: Fahimi, Fanak, et al.
Publicado: (2012)

An XA21-Associated Kinase (OsSERK2) Regulates Immunity Mediated by the XA21 and XA3 Immune Receptors
por: Chen, Xuewei, et al.
Publicado: (2014)

Superior Weight Loss With Patient-Driven, Fluoroscopically Guided Band Adjustment Following Laparoscopic Adjustable Gastric Banding
por: Sarker, Sharfi, et al.
Publicado: (2005)

Xa tantlin lisantiago /
por: Ibarra, José Xochihua
Publicado: (1993)

Coagulation Factor Xa
por: Brown, Mark A., et al.
Publicado: (2013)

Antifactor Xa activity in critically ill patients receiving antithrombotic prophylaxis with standard dosages of certoparin: a prospective, clinical study
por: Jochberger, Stefan, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_ccsf89d7pkn91e7m325i26v5c1